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INTRODUCTION 
 
 
Nodular thyroid disease is a common disorder & the incidence increases 
with age. The prevalence of nodular goitre is 4-7%, but the autopsy studies 
& USG have shown that the true incidence is to be around 50% in the adult 
population. Most thyroid nodules are benign & most of them are adenomas. 
Although a majority of the nodules are benign & some are shown to be 
malignant. Thyroid cancers are comparatively rare disorders.  
 
Preoperative identification & evaluation of these nodules is very 
important. But this distinction often proved difficult with the reliance on the 
clinical assessment & investigations of low sensitivity & specificity. 
According to the clinical diagnosis and most importantly tissue diagnosis, 
the treatment approach can be modified. 
 
                The FNAC is said to be the gold standard for the diagnosis of 
SNG, but the FNAC has got its own pitfalls because of false negatives & 
false positives reports & the same time the results have   inter-observer 
variation & need an experienced histopathologist. Even FNAC has got less 
specificity in identifying the micro-papillary projection & can’t differentiate 
between follicular adenoma & carcinoma. 
 
                 The uses of USG & radioisotope studies are often additive but not 
much of value in confirming the diagnosis particularly in malignancy. So 
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surgery of any type plays an important role in the treatment as well as the 
diagnostic aspect but the present trend is to manage benign lesion on FNAC 
with conservative line of management reserving surgery for the malignant 
lesions & suspected malignancies.    
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STUDY 
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AIM 
 
 
9 To review data regarding incidence of the solitary nodular goitre 
 
9 To analyse & discuss the various clinical presentation 
  
9 To find out the percentage of malignancy in solitary nodular goitre 
 
9 To confirm the role of surgery as the diagnostic & therapeutic 
modality & to discuss the revised indication for surgeries 
 
9 To stress the importance of histopathological examination as the 
final & confirmatory evidence of diagnosis 
 
9 To analyse the pattern of disease affecting SNG based on HPE 
 
9 To compare the data from this study with the other established 
studies 
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SURGICAL ANATOMY 
Historical Background 
 
Goiters (from the Latin guttur, throat), defined as an enlargement of 
the thyroid, have been recognized since 2700 B.C. In 1619, Hieronymus 
Fabricius ab Aquapendente recognized that goiters arose from the thyroid 
gland. The term thyroid gland (Greek thyreoeides, shield-shaped) is, 
however, attributed to Thomas Wharton in his Adenographia (1656).  Burnt 
seaweed was considered to be the most effective treatment for goiters.  
The most notable thyroid surgeons were Emil Theodor Kocher 
(1841–1917) Theodor Billroth (1829–1894), who performed thousands of 
operations with increasingly successful results.  After total thyroidectomy, 
patients (children) became myxedematous with cretinous features. 
Myxedema was first effectively treated in 1891 by George Murray, who 
used a subcutaneous injection of an extract of sheep's thyroid; later, Edward 
Fox demonstrated that oral therapy was equally effective. In 1909, Kocher 
was awarded the Nobel Prize for medicine in recognition "for his works on 
the physiology, pathology, and surgery of the thyroid gland." 
General Topography: The thyroid gland consists typically of two lobes, a 
connecting isthmus, and an ascending pyramidal lobe. One lobe, usually the 
right, may be smaller than the other (7 percent) or may even be completely 
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absent (1.7 percent). The isthmus is absent in about 10 percent of thyroid 
glands, and the pyramidal lobe is absent in about 50 percent. A minute 
epithelial tube or fibrous cord, the thyroglossal duct, almost always extends 
between the thyroid gland and the foramen cecum of the tongue. 
The thyroid gland normally extends from the level of the 5th cervical 
vertebra to the body of the 1st thoracic vertebra. It may lie higher (lingual 
thyroid), but rarely lower. The normal thyroid gland weighs about 30 g in 
the adult —somewhat more in females than in males. Each lobe is 
approximately 5 cm in length, 3 cm at its greatest width, and 2-3 cm thick. 
The isthmus connecting the two lobes is about 1.3 cm in breadth. The lobes 
have a broad lower portion and a relatively conical apex. 
Embryogenesis 
Normal Development 
The thyroid gland appears by the end of the third week as an 
epithelial thickening of the floor of the pharynx at the level of the first 
pharyngeal pouch. This, the large median thyroid anlage, may be a 
diverticulum or a solid bud. Cranial growth of the tongue, together with 
elongation of the embryo, carries the origin of the thyroid gland far cranial 
to the gland itself. The site of this origin is the foramen cecum of the adult 
tongue. In some individuals it is not grossly visible. 
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The thyroid gland remains connected with the foramen cecum by a 
minute, solid thyroglossal duct that passes through, or anterior to, the hyoid 
bone. By the fifth week of gestation, this duct usually becomes fragmented; 
persistence of any portion is not unusual. In about 50 percent of the 
population, the duct can be traced distally to the pyramidal lobe of the 
thyroid gland. The developing gland, at first an irregular plate, develops two 
lateral wings connected by the isthmus. Follicles appear during the second 
month of gestation and increase through the fourth month. Colloid 
formation and uptake of radioactive iodine begin at about the eleventh 
week. 
Epithelial structures, the paired lateral anlages, are formed from the 
ventral portions of the fourth and fifth branchial pouches. This structure, the 
well-known ultimobranchial body (caudal pharyngeal pouch complex), 
becomes lost in the developing thyroid gland, and its cells become dispersed 
as the C (calcitonin) cells among the thyroid follicles. 
Present evidence suggests that the primary origin of the calcitonin-
producing cells of the thyroid gland is the neural crest of the embryo. From 
the neural crest these cells migrate to the ultimobranchial body, and later 
become part of the thyroid gland.  
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THYROID ANATOMY
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Capsule of the Thyroid Gland 
The thyroid gland has a connective tissue capsule which is continuous 
with the septa, and which makes up the stroma & is the true capsule of the 
thyroid. External to the true capsule is a layer of fascia derived from the 
pretracheal fascia. This is the false capsule, also called the perithyroid 
sheath or surgical capsule. Anteriorly and laterally this fascia is well 
developed; posteriorly it is thin and loose, permitting enlargement of the 
thyroid gland posteriorly. There is a thickening of the fascia that fixes the 
back of each lobe to the cricoid cartilage. Such thickenings are the ligaments 
of Berry. The false capsule, or fascia, is not removed with the gland during 
thyroidectomy. 
The superior parathyroid glands normally lie between the true capsule 
of the thyroid and the fascial false capsule. The inferior parathyroids may be 
between the true and false capsules, within the thyroid parenchyma, or lying 
on the outer surface of the fascia. 
Vascular Supply 
The thyroid gland competes with the adrenal glands for having the 
greatest blood supply per gram of tissue.  
Arteries: Two paired arteries, the superior and inferior thyroid arteries, and 
an inconstant midline vessel, the thyroid ima artery, supply the thyroid. 
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Superior Thyroid Artery: The superior thyroid artery arises from the 
external carotid artery just above, at, or just below the bifurcation of the 
common carotid artery. It passes downward and anteriorly to reach the 
superior pole of the thyroid gland. In part of its course, the artery parallels 
the external branch of the superior laryngeal nerve which supplies the 
cricothyroid muscle and the cricopharyngeus muscle, the lowest voluntary 
part of the pharyngeal musculature. There are six branches of the superior 
thyroid artery: the infrahyoid, sternocleidomastoid, superior laryngeal, 
cricothyroid, inferior pharyngeal constrictor, and terminal branches of the 
artery for the blood supply of the thyroid and parathyroid glands. Usually 
there are two branches to the thyroid —the anterior and posterior— but 
occasionally there may be a third, the so-called lateral branch. 
At the superior pole, the superior thyroid artery divides into anterior 
and posterior branches. The anterior branch anastomoses with the 
contralateral artery. The posterior branch anastomoses with branches of the 
inferior thyroid artery. From the posterior branch, a small parathyroid artery 
passes to the superior parathyroid gland. 
Inferior Thyroid Artery: The inferior thyroid artery usually arises from the 
thyrocervical trunk, but in about 15 percent of individuals it arises directly 
from the subclavian artery.  After piercing the prevertebral fascia, the artery 
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divides into two or more branches as it crosses the ascending recurrent 
laryngeal nerve.  
The recurrent laryngeal nerve may pass anterior or posterior to the 
artery, or between its branches. The lowest branch sends a twig to the 
inferior parathyroid gland and supplies the lower pole of the thyroid gland. 
The upper branch supplies the posterior surface of the gland, usually 
anastomosing with a descending branch of the superior thyroid artery.  
Thyroid Ima Artery: The thyroid ima artery is unpaired and inconstant. It 
arises from the brachiocephalic artery, the right common carotid artery, or 
the aortic arch. It occurs in about 10 percent of individuals. Its position 
anterior to the trachea makes it important in tracheostomy. 
Veins 
Veins of the thyroid gland form a plexus of vessels lying in the 
substance and on the surface of the gland. The plexus is drained by three 
pairs of veins, the superior, middle, and inferior thyroid veins. 
Superior Thyroid Vein: The superior thyroid vein accompanies the superior 
thyroid artery. Emerging from the superior pole of the thyroid, the vein 
passes superiorly and laterally across the omohyoid muscle and the common 
carotid artery to enter the internal jugular vein alone or with the common 
facial vein. 
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Middle Thyroid Vein: No artery accompanies it. It crosses the common 
carotid artery to open into the internal jugular vein. This vein may be absent 
or, occasionally, double. The extra vein is inferior to the normal one; it has 
been called the "fourth" thyroid vein. The importance of these middle 
thyroid veins is in their vulnerability during thyroidectomy. 
Inferior Thyroid Vein:  The right vein leaves the lower border of the 
thyroid gland, passes anterior to the brachiocephalic artery, and enters the 
right brachiocephalic vein. The left vein crosses the trachea to enter the left 
brachiocephalic vein. Rarely, the right vein crosses the trachea to enter the 
left brachiocephalic vein, sometimes forming a common trunk with the left 
vein. This common trunk is called the thyroid ima vein. 
Lymphatic System: The thyroid gland is endowed with an extensive 
network of lymphatics. Intraglandular lymphatic vessels connect both 
thyroid lobes through the isthmus and also drain to perithyroidal structures 
and lymph nodes. Regional lymph nodes include pretracheal, paratracheal, 
perithyroidal, recurrent laryngeal nerve, superior mediastinal, 
retropharyngeal, oesophageal, and upper, middle, and lower jugular chain 
nodes. These lymph nodes can be classified into seven levels. The central 
compartment nodes located in the area between the two carotid sheaths, 
whereas nodes lateral to the vessels are present in the lateral compartment.  
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Nerves: The left RLN arises from the vagus nerve where it crosses the 
aortic arch, loops around the ligamentum arteriosum and ascends medially 
in the neck within the tracheoesophageal groove. The right RLN arises from 
the vagus at its crossing with the right subclavian artery. The nerve passes 
posterior to the artery before ascending in the neck, its course being more 
oblique than the left RLN. Along their course in the neck, the RLNs may 
branch, and pass anterior, posterior or interdigitate with branches of the 
inferior thyroid artery. The right RLN may be nonrecurrent in 0.5 to 1% of 
individuals and is often associated with a vascular anomaly in this situation. 
Nonrecurrent left RLNs are rare, but have been reported in patients with 
situs inversus and a right-sided aortic arch. The RLN may branch in its 
course in the neck, and identification of a small nerve should alert the 
surgeon to this possibility. Identification of the nerves or their branches 
often necessitates mobilization of the most lateral and posterior extent of the 
thyroid gland, the tubercle of Zuckerkandl, at the level of the cricoid 
cartilage. The last segments of the nerves often course below the tubercle 
and are closely approximated to the ligament of Berry. Branches of the 
nerve may traverse the ligament in 25% of individuals, and are particularly 
vulnerable to injury at this junction. The recurrent laryngeal nerves 
terminate by entering the larynx posterior to the cricothyroid muscle.The 
RLNs innervate all the intrinsic muscles of the larynx, except the 
cricothyroid muscles, which are innervated by the external laryngeal nerves. 
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Injury to one RLN leads to paralysis of the ipsilateral vocal cord, which 
comes to lie in the paramedian or the abducted position. The paramedian 
position results in a normal, but weak voice, whereas the abducted position 
leads to a hoarse voice and an ineffective cough. Bilateral RLN injury may 
lead to airway obstruction, necessitating emergency tracheostomy, or loss of 
voice. If both cords come to lie in an abducted position, air movement can 
occur, but the patient has an ineffective cough and is at increased risk of 
repeated respiratory tract infections from aspiration. 
The superior laryngeal nerve:The superior laryngeal nerves also arise from 
the vagus nerves. After their origin at the base of the skull, these nerves 
travel along the internal carotid artery and divide into two branches at the 
level of the hyoid bone. The internal branch of the superior laryngeal nerve 
is sensory to the supraglottic larynx. Injury to this nerve is rare in thyroid 
surgery, but its occurrence may result in aspiration. The external branch of 
the superior laryngeal nerve lies on the inferior pharyngeal constrictor 
muscle and descends alongside the superior thyroid vessels before 
innervating the cricothyroid muscle. Cernea and associates proposed a 
classification system to describe the relationship of this nerve to the superior 
thyroid vessels. The type 2a variant, in which the nerve crosses below the 
tip of the thyroid superior pole, occurs in up to 20% of individuals and 
places the nerve at a greater risk of injury. Therefore, the superior pole 
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vessels should not be ligated en masse, but should be individually divided, 
low on the thyroid gland, and dissected lateral to the cricothyroid muscle. 
This nerve also has been called the Amelita Galla Curci or "high note" 
nerve after the opera singer. Injury to this nerve leads to inability to tense 
the ipsilateral vocal cord and hence difficulty "hitting high notes," 
projecting the voice, and voice fatigue during prolonged speech. 
Histology 
The thyroid gland is surrounded by the thyroid capsule, which is a 
thin layer of connective tissue. From the capsule, several septa extend 
within the thyroid parenchyma, which is subdivided into several lobules. 
The thyroid is divided into lobules that contain 20 to 40 follicles. There are 
roughly 3 x 106 follicles in the adult male thyroid gland. The follicles are 
spherical and average 30 µm in diameter. Epithelial cells (cuboidal or 
squamous) form the thyroid follicles; they are separated by thin connective 
stroma which is rich in both lymphatic and blood vessels. Small bundles of 
nerves are present. There is a colloidal gelatinous collection in the center of 
the follicle. Each follicle has two types of cells: follicular and parafollicular, 
or C cells. The follicular cells are responsible for the following actions: 
synthesis of thyroglobulin, iodination, storage of thyroglobulin, resorption 
of thyroglobulin, hydrolysis of thyroglobulin, and release of thyroid 
hormone into the blood and lymphatics.   
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PHYSIOLOGY 
Iodine Metabolism 
The average daily iodine requirement is 0.1 mg, which can be derived 
from foods such as fish, milk, and eggs, or as additives in bread or salt. In 
the stomach and jejunum, iodine is rapidly converted to iodide and absorbed 
into the bloodstream, from where it is distributed uniformly throughout the 
extracellular space. Iodide is actively transported into the thyroid follicular 
cells by an ATP-dependent process. In fact, the thyroid is the storage site of 
greater than 90% of the body's iodine content and accounts for one-third of 
the plasma iodine loss. The remaining plasma iodine is cleared via renal 
excretion 
Thyroid Hormone Synthesis, Secretion, and Transport 
The synthesis of thyroid hormone consists of several steps. The first 
step, iodide trapping, involves active (ATP-dependent) transport of iodide 
across the basement membrane of the thyrocyte via an intrinsic membrane 
protein, the Na+/I– symporter (NIS). Thyroglobulin (Tg) is a large (660-kDa) 
glycoprotein, which is present in thyroid follicles and has four tyrosyl 
residues. The second step in thyroid hormone synthesis involves oxidation 
of iodide to iodine and iodination of tyrosine residues on Tg, to form 
monoiodotyrosines (MITs) and diiodotyrosines (DITs). Both processes are 
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catalyzed by thyroid peroxidase. The recently identified protein pendrin is 
thought to mediate iodine efflux at the apical membrane. The third step 
leads to coupling of two DIT molecules to form tetraiodothyronine or 
thyroxine (T4), and one DIT molecule with one MIT molecule to form 
3,5,3'-triiodothyronine (T3) or reverse 3,3',5'-triiodothyronine (rT3). When 
stimulated by TSH, thyrocytes form pseudopodia that encircle portions of 
cell membrane containing thyroglobulin, which, in turn, fuse with enzyme-
containing lysosomes. In the fourth step, thyroglobulin is hydrolyzed to 
release free iodothyronines (T3 and T4) and mono- and diiodotyrosines. The 
latter are deiodinated in the fifth step to yield iodide, which is reused in the 
thyrocyte.  
Comparison of     T3 and T4     
 T3 T4 
Production rate (nmol/day) 50 110 
 Fraction from thyroid 0.2 1.0 
Relative metabolic potency 1.0 0.3 
Serum concentration 
 Total (nmol/L) 1.8 100 
 Free (pmol/L) 5 20 
Fraction of total hormone in free form (× 10- 2) 0.3 0.02 
Distribution volume (L) 40 10 
Fraction intracellular 0.64 0.15 
Half-life (days) 0.75 6.7 
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KEY STEPS IN SYNTHESIS OF THYROID HORMONE 
 
1.  Active uptake of iodide (I-) in exchange for Na+. 
2. Iodide may be discharged from the follicular cell by administration of 
competing ions such as perchlorate, bromide or chlorate. 
3. Iodide uptake, the main control point for hormone synthesis, is stimulated 
by TSH. 
4. Oxidation of iodide by hydrogen peroxide (H2O2) to form active iodine.   
     The reaction is catalyzed by thyroid peroxidase (TPO). 
5. Active transport of iodine across the apical surface of the follicular cell. 
6. Incorporation of active iodine into the tyrosine residues of thyroglobulin 
molecules to form mono- and di-iodotyrosines (MIT and DIT). 
7. Uptake of the thyroglobulin into the lumen of the follicle and lining of 
iodinated tyrosine residues. 
8. About 1% of stored colloid is removed each day. When the gland is very 
active this may rise to nearly 100% and colloid stores are depleted. 
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KEY STEPS IN SYNTHESIS OF THYROID HORMONE 
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SCHEMATIC REPRESENTATION OF THYROID HORMONE 
SYNTHESIS AND RELEASE  
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PHYSIOLOGICAL EFFECTS OF THYROID HORMONES 
 
Target 
Tissue 
Effect Mechanism 
Heart Chronotropic Increase number of -adrenergic 
receptors. 
  Inotropic Enhance responses to circulating 
catecholamines. 
    Increase proportion of -myosin 
heavy chain (with higher ATPase 
activity). 
Adipose 
tissue 
Catabolic Stimulate lipolysis. 
Muscle Catabolic Increase protein breakdown. 
Bone Developmental Promote normal growth and skeletal 
development. 
Nervous 
system 
Developmental Promote normal brain development. 
Gut Metabolic Increase rate of carbohydrate 
absorption. 
Lipoprotein Metabolic Stimulate formation of LDL 
receptors. 
Other Calorigenic Stimulate oxygen consumption by 
metabolically active tissues 
(exceptions: testes, uterus, lymph 
nodes, spleen, and anterior pituitary). 
    Increase metabolic rate. 
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 PITUITARY THYROID AXIS 
 
Synthesis & liberation of thyroid hormones is controlled by TSH 
from anterior pituitary. Secretion of TSH depends on the level of circulating 
thyroid hormones in a classical negative feed back manner. Regulation of 
TSH secretion also results from the action of thyrotropin releasing hormone 
(TRH) produced in hypothalamus. 
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PATHOLOGY 
 
A single palpable nodule in otherwise impalpable thyroid gland is 
called solitary nodule thyroid. A single discrete nodule in a palpable thyroid 
gland is called dominant nodule. Hence, the majority of thyroid nodules are 
benign and do not require removal. Therefore, it is of utmost importance to 
determine which patients with solitary thyroid nodule would benefit from 
surgery. 
FORMATION OF NODULES 
  
A loss of co-ordination between iodine metabolism, epithelial 
multiplication, thyroglobulin synthesis and colloid endocytosis are 
important in the genesis of nodule. Iodine deficiency and ingestion of 
goitrogens are the commonest cause of goitre formation. Iodine deficiency 
or goitrogens or hereditary factors lead to decrease in serum thyroid 
hormones with followed by increase in TSH which will produce diffuse 
hyperplastic goitre. The patient will become euthyroid because of normal 
thyroid hormone level, TSH level drops down and goitre disappears. If it 
persists after that it is a colloid goitre with inactive follicles. Because of 
fluctuation in TSH level, and varied response of cells to TSH, mixed active 
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and inactive follicles are formed. In active follicles, because of high 
vascularity, haemorrhage occurs with central necrosis. Growth stimulating 
antibodies are also responsible for multinodular goitre. Patient is usually 
euthyroid. Firm painless nodules are palpable; hardness may be due to 
calcification. Pain & sudden increase in size may be due to haemorrhage and 
simulate malignancy. Many thyroid disorders, both benign & malignant may 
manifest as solitary nodule. 
 
CAUSES OF SOLITARY NODULE  
A. CYST 
                         Simple  
                         Mixed – cystic and solid or complex  
B.PALPABLE NODULE OF TRUE MULTINODULAR GOITRE 
C.THYROIDITIS 
                         Hashimoto’s thyroiditis 
                          Sub-acute 
D.INFECTION 
                       Granulomatous disease 
                        Abscess 
E.ADENOMA 
F.TOXIC ADENOMA 
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G. MALIGNANCY 
Carcinoma – primary                 Differentiated  
                                                   Papillay 
                                                  Follicular 
                                                  Medullary thyroid carcinoma 
                                                  Undifferentiated  
                                                  Anaplastic  
         - metastatic  
     Lymphoma  
Clinically palpable nodule of a multinodular goitre is the most common 
cause of solitary nodule thyroid. 
ADENOMA 
                    Virtually all adenomas of thyroid present as a small discrete 
solitary nodule. They occur most commonly in young and middle aged 
women. They rarely exceed 3 cm. Almost all adenomas are of follicular 
variety. Rare types are papillary cystadenoma and Hurthle cell adenoma. 
The differentiation of a nodule within a multinodular goitre from an 
adenoma is difficult not only clinically but also anatomically. 
             The morphologic criteria used to identify adenoma are: complete fibrous 
encapsulation, a clear distinction between the architecture inside and outside 
the capsule, compression of thyroid parenchyma around the adenoma, lack 
of multinodularity in the remaining gland. 
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HISTOLOGICAL CLASSIFICATION OF ADENOMA 
 
TYPE-I 
A.EMBRYONAL ADENOMA 
  The follicles are premature, very cellular & arranged in the form of cords. 
B. FETAL ADENOMA 
          Small follicles are arranged closely packed with an abundant connective 
tissue stroma. 
C. SIMPLE ADENOMA  
 
 Composed of closely packed follicles of normal size.  
D.  COLLOID ADENOMA  
 
 Contains dilated follicles filled with colloid.  
E. HURTHLE CELL ADENOMA  
 
 Composed of large granular cells identical to those encountered in 
various non – neoplastic thyroid lesions usually arranged in trabecular 
pattern. 
 
Type II 
 
A. Mircofollicular  
B. Macrofollicular 
C. Atypical adenoma  
 
 Exhibits nuclear atypia, variability in cell morphology, including the 
presence of spindle shaped cells.  
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 Follicular adenomas are differentiated from follicular carcinoma by 
the absence of capsular or vascular invasion.  Thus careful sampling of 
capsule is required to exclude carcinoma.  
 
 Adenomas attain certain size and remain in that because the expansile 
pressure restricts blood supply.  It may suddenly enlarge and may be painful 
because of haemorrhage within the nodule.  Adenomas occasionally have 
some dependence on TSH, so it regressed after administration of thyroid 
hormones.  
Adenomatous goitre  
 
 Adenomatous goitre is usually multinodular but a few may present as 
solitary nodule.  Most patients are euthyroid.  Whether single or numerous, 
adenomatous nodules have similar appearances.  
 
Typical features include  
 
1. Nodularity created by islands of colloid filled or hyperplastic 
follicles.  
2. Random irregular scarring.  
3. Focal haemorrhages and haemosiderin deposition.  
4. Focal calcification in areas of scarring 
5. Microcyst formation.  
 
Microscopically adenomatous nodules are composed of follicles of 
varying size.   Some follicles are distended with colloid and lined by  
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                                                 PAPILLARY CARCINOMA  
 
  
 
 
HASHIMOTO'S THYROIDITIS 1 
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 flattened epithelium, whereas as other are small and are more active 
appearing.  
 
 
CARCINOMA  
 
Papillary Carcinoma: (70%)  
 
            Common in adults and children. Responsible for 30% of the thyroid 
carcinoma occurring below 40 yrs. More common in women.  It grows 
slowly.  Metastases to cervical lymph nodes are common.  About 10-20% 
may present as only cervical lymph node metastases.  The primary is occult 
(lateral aberrant thyroid).  All the lesions below 1.0 cm are called as occult 
or micro carcinoma.  Blood spread is unusual.  Prognosis is good.  10 years 
survival rate is about 70– 80%.  
Histology  
 
Complicated branching tree like pattern of cells outlined by papilliferous 
axial fibrovascular stroma.  Pale, empty nuclei (Orphan Annie eyed nuclei) 
and Psammoma bodies are present.  Papillary carcinoma is subjected to the 
influence of pituitary T.S.H.  
Follicular carcinoma (25%) 
 
It is a well differentiated carcinoma of the thyroid but more aggressive 
than papillary carcinoma.  More common in women.  Peak incidence occurs 
in 5th and 6th decade.  
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FOLLICULAR CARCINOMA  
 
   
 
 
 
 
             MEDULLARY CARCINOMA 
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Two types: 
 
i) Encapsulated - Less common  
ii) Invasive mass  
 
Haemorrhages, cystic degeneration and necrosis are common.  
Microscopically picture is that of adenocarcinoma with considerable range 
in size and differentiation of glands.  Blood spread occurs in 70% cases.  
Commonest sites are lungs, bones, brain etc. Regional lymph nodes are 
involved in only 5% of cases.  
 
Medullary carcinoma  
 
Derived from parafollicular cells (C cells).  It is an APUDOMA.  80% 
occur sporadically usually in adults.  10-20% occurs in children and 
teenagers with associated syndromes.  
 MEN IIa : MTC, Phaechromocytomas, parathyroid tumours.  
MEN IIb : MTC, Phaechromocytomas + Mucosal neuroma,  
Marfanoid features, ganglioneuromatosis.  
 
 90% of the patients secrete calcitonin.  Less frequently histamine, 
prostaglandins, ACTH and serotonin are secreted.  It may present as a single 
nodule or multiple nodules.  Sporadic forms occur in 5th – 6th decades.  
Often present in advanced forms.  Familial type presents in second decade.  
Associated endocrine abnormalities bring the patient early.  Diarrhoeas is 
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present in up to 30% of patients.  Metastasis is usually to regional nodes 
(50%), lung, liver and bone.  Medullary carcinoma is not TSH dependent.  It 
does not take up radio iodine.  Diagnosis of medullary carcinoma can be 
made by stimulating calcitonin secretion by Pentagastrin and calcium 
infusions.  
 
Anaplastic carcinoma  
 
 Usually occurs in 7th and 8th decades of life, it is a rapidly growing, 
locally infiltrative tumour with very poor prognosis. It spreads by 
lymphatics and by blood stream.  Two histological types are small cell 
carcinoma and giant cell carcinoma.  I year survival is about 20%. Other 
tumours like lymphoma, sarcoma and secondaries also occur in thyroid.  
Secondary tumours usually arise from kidney, breast, colon, melanomas.  
Thyroiditis 
 
(i) Hashimoto’s Thyroditis  
 
 It is an autoimmune thyroiditis.  It is the commonest cause for 
goitrous hypothyroidism in places where iodine intake is adequate.  It is a 
major cause for nonendemic goitre in children.  The goitre is due to thyroid 
growth immunoglobulins like auto antibodies to thyrotrophin receptors, 
follicular microsomes, and thyroglobulin.  Thyroid parenchyma is replaced 
by fibrous tissue because of the infiltration by lymphoid cells.  So 
eventually hypothyroidism develops.  Sometimes in the midcourse patient 
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may develop thyrotoxicosis called ‘Hashitoxicosis’. More common in 
women at menopausal age.  Usually both the lobes are involved.  
Nevertheless one lobe is larger than the other.  It is lobulated and rubbery in 
consistency.  It may be associated with pernicious anaemia, vitiligo, and 
Rheumatoid arthritis etc. 
 
Histology  
 Excessive replacement of parenchyma by lymphocytes, plasma cells, 
macrophages, lymphoid germinal centers.  Follicular cells are transformed 
into eosinophilic granular cystoplasmic cells called Hurthle cells (or 
oncocytes or Askanazy cells).  Diagnosis rests on measurement of serum 
auto antibodies by Radio Immuno Assay.  It is positive in over 85% of 
cases.  Lymphoma may develop in Hashimoto’s thyroiditis.  
(ii) Subacute Thyroditis (De Quervain’s Thyroiditis) 
 Causative agent is a virus, probably mumps virus.  Patient has flu like 
illness followed by pain and rapid onset of swelling of thyroid.  Swelling 
may be diffuse or asymmetrical, and tender on palpation.  During active 
phase patient may develop hyperthyroidism, then due to extensive 
destruction hypothyroidism develops.  
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Histology: 
 Aggregation of macrophages admixed with multi nucleated giant 
cells.  It is a self limiting condition. Acute bacterial thyroiditis is rare.  
Commonest organisms are staphylococcus.  
 
(III) Riedel’s Thyroiditis (Ligneous Thyroiditis). 
 Aetiology is unknown.  There is extensive fibrosing reaction that 
destroys more or less all the thyroid gland.  The fibrous tissue may extend 
beyond the capsule and involve other structures in the neck.  More common 
in females. It is characterized by painless enlargement of thyroid, woody 
hard in consistency, asymmetrical, pressure symptoms may be present 
especially tracheal compression.  It may be associated with retroperitoneal 
fibrosis.  Occasionally it may be associated with sclerosing cholangitis.  
About 25-50% of the patients are hypothyroid.  
 
Toxic Adenoma: 
This type produces hormones in sufficient quantity to give rise to 
hyperthyroidism.  Thyroxine output is not controlled by TSH or LATS. It is 
an autonomous tumour.  Patient has increased metabolic rate, loss of weight, 
intolerance to heat, tremors, and fibrillations.  Usually there is no 
exophthalmos.  Radioiodine scan shows it to be a hot nodule.  
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CLINICAL PRESENTATION 
 
Patients with solitary nodule in thyroid may present for: 
 
• Toxic symptoms (autonomous, hyper functioning nodule).  
• Pressure symptoms – dyspnoea, dysphagia, hoarseness of voice 
and rarely superior venacaval obstruction.  
• Metastatic disease in the neck lymph nodes 
• Distant metastasis.  
• Cosmetic reasons.  
 
CLINICAL RISK FACTORS  
 
Age 
 
 The risk of cancer in a solitary thyroid nodule is more than 10% in 
adults.  This risk is more in teenagers and after 60 years of age (30% - 
40%).  
 
Sex 
 
 Nodules in men are more likely to harbour malignancy than in 
women.  
 
Growth Patterns  
 
 A nodule that has appeared recently or one that has undergone 
progressive enlargement over months is suspicious of malignancy.   
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A CASE OF FOLLICULAR ADENOMA 
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However sudden painful enlargement of a nodule is usually due to 
haemorrhage with in the nodule.   
 
IRRADIATION  
 
 The finding of solitary thyroid nodule in an individual with a history 
of external irradiation therapy over face, neck and chest should be regarded 
with a high degree of suspicion for the presence of malignancy.  
 
FAMILY HISTORY  
 
 The presence of a solitary nodule in a patient with a family history of 
thyroid malignancy increases the risk for malignancy in the nodule.  
 
PHYSICAL CHARACTERISTICS OF THYROID NODULE 
 
1. Single versus multiple: 
 
 Malignancy occurs in 10-20% of single thyroid nodules but in only 3-   
          5% multinodular  goitre. 
 
2. Consistency and fixation: 
 
 Hard consistency and the clinical impression of fixation implying  
invasion of adjacent structures also suggest malignancy.  Indeed the  
majority of cancers occurring in single nodules are mobile and  
indistinguishable from benign lesions. 
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Solitary nodule thyroid 
 
 
  
 
         
 
          
Follicular adenoma 
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3. Recurrent nerve paralysis.  
 
 In the absence of previous neck surgery, it is virtually pathognomonic  
of malignancy.  
4. Obstructive signs: 
 
 Clinical evidence of obstruction of the airway or of the great veins of  
neck and mediastinum by a solitary thyroid nodule is rare, but when  
present, should raise the suspicion of malignancy.  
 
5. Lymph nodes  
 
 Associated palpable cervical lymph adenopathy points strongly to  
cancer  
 
6. Distant metastasis.  
 
CLINICOPATHOLOGICAL STAGING OF THYROID 
CARCINOMA; (DEGROOT) 
 
I. A. Unilateral confined to thyroid 
B. Bilateral or multifocal  
 
II. A. Unilateral Significant cervical nodes  
B. Bilateral cervical or mediastinal lymph nodes  
III. Local invasion with or without positive nodes  
 
IV. Distant metastasis  
 
TNM classification is separate for each type of thyroid carcinoma.  
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MULTINODULAR GOITRE  
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Definitions of low risk and high risk for differentiated carcinoma as per 
lahey  clinic.  
* AGES Scale  : Age, Grade of Tumour, Extent of disease, 
Size of tumor  
* MACIS Scale : Metastases: Age, extent of Clearance, 
Invasion,  
Size of tumour.  
* AMES Scale  : Age, Metastases, Extent of invasion, Size of  
tumour.  
* Men of 40 years and younger, women of 50 years and younger 
without distant metastases.  
* All older patients with intra thyroid papillary carcinoma of follicular 
carcinoma with minor capsular involvement, in association with 
tumors less than 5 cm in diameter and no distant metastases.  
 
High risk group: 
 
• All patients with distant metastases 
• All older patients with extra thyroid papillary carcinoma or 
follicular carcinoma with major capsular involvement and tumors 
5 cm in diameter or larger regardless of extent of disease.  
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TNM STAGING
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Primary tumor 
TX: Primary tumor cannot be assessed  
T0: No evidence of primary tumor  
T1: The tumor is 2 cm or less in diameter  
T2: Tumor is between 2 cm and 4 cm across  
T3: Tumor is larger than 4 cm limited to thyroid or with 
extrathyroidal extension 
T4a: Tumor of any size and has grown extensively beyond the thyroid 
capsule to invade soft  tissues, larynx,trachea, esophagus RLN  
T4b: Tumor invades prevertebral fascia,encases  carotid artery 
/mediastinal vessels 
For anaplastic thyroid cancers:  
T4a: Tumor is still within the thyroid and may be resectable  
T4b: Tumor has grown outside of the thyroid and is not resectable  
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Regional lymph Nodes 
NX: Regional (nearby) lymph nodes cannot be assessed  
N0: No regional lymph nodes spread 
N1: Spread to regional nodes present 
N1a: Metastases to level VI (cervical)  
N1b: Metastases to unilateral bilateral or contralateral neck or the upper  
mediastinal nodes 
Distant Metastases:  
MX: Presence of distant metastasis (spread) cannot be assessed  
M0: No distant metastasis  
M1: Distant metastasis is present 
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STAGE GROUPING 
 
Papillary or Follicular Tumors 
Stage TNM 
Younger than age 45 Years   
  I Any T, Any N, M0 
  II Any T, Any N, M1 
Age 45 Years and older   
  I T1, N0, M0 
  II T2, N0, M0 
  III T3, N0, M0; T1-3, N1a, M0 
  IVA T4a, N0-1a, M0; T1-4a, N1b, M0 
  IVB T4b, Any N, M0 
  IVC Any T, any N, M1 
Medullary Thyroid Cancer 
Stage TNM 
  I T1, N0, M0 
  II T2-3, N0, M0 
  III T1-3, N1a, M0 
  IVA T4a, N0-1a, M0; T1-4a, N1b, M0 
  IVB T4b, any N, M0 
  IVC Any T, Any N, M1 
Anaplastic Cancer 
Stage TNM 
  IVA T4a, Any N, M0 
  IVB T4b, Any N, M0 
  IVC Any T, Any M, M1  
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                     Evaluation of Patients with Thyroid Disease 
Tests of Thyroid Function  
Serum TSH: The tests for serum TSH (normal  0.5 to 5 µU/mL) are based 
on the principle that monoclonal TSH antibodies are bound to a solid matrix 
and bind serum TSH. The amount of serum TSH is proportional to the 
amount of bound secondary antibody (immunometric assay). Older 
radioimmunoassays for TSH were able to detect elevated TSH levels in 
hypothyroidism, but were not sensitive enough to detect suppressed levels 
of TSH characteristic of hyperthyroidism. Newer, second-generation, 
"sensitive" TSH assays can measure levels less than 0.1 µU/mL and third-
generation or "supersensitive or ultrasensitive" assays can detect TSH levels 
as low as 0.01 µU/mL. Serum TSH levels reflect the ability of the anterior 
pituitary to detect free T4 levels. There is an inverse relationship between 
the free T4 level and the logarithm of the TSH concentration—small 
changes in free T4 lead to a large shift in TSH levels. Thus, the ultrasensitive 
TSH assay has become the most sensitive and specific test for the diagnosis 
of hyper- and hypothyroidism and for optimizing T4 replacement and 
suppressive therapy. 
Total T4 and Total T3 : Total T4 (reference range: 55 to 150 nmol/L) and T3 
(reference range: 1.5 to 3.5 nmol/L) levels are measured by 
radioimmunoassay and measure both the free and bound components of the 
55 
 
hormones. Total T4 levels reflect the output from the thyroid gland, whereas 
T3 levels in the non-stimulated thyroid gland are more indicative of 
peripheral thyroid hormone metabolism and are, therefore, not generally 
suitable as a general screening test. Total T4 levels are increased not only in 
hyperthyroid patients, but also in those patients with elevated thyroglobulin 
levels secondary to pregnancy, estrogen/progesterone use, or congenital 
diseases. Similarly, total T4 levels decrease in hypothyroidism and in 
patients with decreased thyroglobulin levels caused by anabolic steroid use 
and by protein-losing disorders such as nephrotic syndrome. Individuals 
with these latter disorders may be euthyroid if their free T4 levels are 
normal. Measurement of total T3 levels is important in clinically 
hyperthyroid patients with normal T4 levels, who may have T3 
thyrotoxicosis. As discussed previously, total T3 levels are often increased in 
early hypothyroidism. 
Free T4 and Free T3: These radioimmunoassay-based tests are a sensitive 
and accurate measurement of biologically active thyroid hormone. Free T4 
(reference range: 12 to 28 pmol/L) estimates are not performed as a routine 
screening tool in thyroid disease. Use of this test is confined to cases of 
early hyperthyroidism in which total T4 levels may be normal but free T4 
levels are raised. In patients with end-organ resistance to T4 (Refetoff 
syndrome), T4 levels are increased, but TSH levels usually are normal. Free 
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T3 (reference range: 3 to 9 pmol/L) is most useful in confirming the 
diagnosis of early hyperthyroidism, in which levels of free T4 and free T3 
rise before total T4 and T3. Free T4 levels may also be measured indirectly 
using the T3 resin-uptake test. If free T4 levels are increased, fewer 
hormone-binding sites are available for binding radiolabeled T3 that has 
been added to the patient's serum. Therefore, more T3 binds with an ion-
exchange resin and the T3 resin uptake is increased. 
Thyrotropin-Releasing Hormone : This test is useful to evaluate pituitary 
TSH secretory function and is performed by administering 500 µg of TRH 
intravenously and measuring TSH levels after 30 and 60 minutes. In a 
normal individual, TSH levels should increase at least  6 µIU/mL from the 
baseline.  
Thyroid Antibodies: Thyroid antibodies include antithyroglobulin (anti-
Tg), antimicrosomal or antithyroid peroxidase (anti-TPO) and thyroid-
stimulating immunoglobulin (TSI). Anti-Tg and anti-TPO antibody levels 
do not determine thyroid function; instead, they indicate the underlying 
disorder, usually an autoimmune thyroiditis. Approximately 80% of patients 
with Hashimoto's thyroiditis have elevated thyroid antibody levels, but 
levels may also be increased in patients with Graves' disease, multinodular 
goiter, and, occasionally, with thyroid neoplasms. 
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Serum Thyroglobulin: Thyroglobulin is increased dramatically in 
destructive processes of the thyroid gland, such as thyroiditis or overactive 
states such as Graves' disease and toxic multinodular goiter. Used in 
monitoring patients with differentiated thyroid cancer for recurrence, 
particularly after total thyroidectomy and radioactive iodine ablation. 
Thyroid Imaging 
Radionuclide Imaging 
Both iodine-123 (123I) and iodine-131 (131I) are used to image the 
thyroid gland. The former emits low-dose radiation, has a half-life of 12 to 
14 hours, and is used to image lingual thyroids or goitres. In contrast, 131I 
use leads to higher-dose radiation exposure and has a half-life of 8 to 10 
days. Therefore, this isotope is used to screen and treat patients with 
differentiated thyroid cancers for metastatic disease. The images provide 
information about the size shape of the gland, distribution of functional 
activity. Areas that trap less radioactivity than the surrounding gland are 
termed "cold" , whereas areas that demonstrate increased activity are termed 
"hot." The risk of malignancy is higher in "cold" lesions (15 to 20%) than in 
"hot" or "warm" lesions (<5%). Technetium-99m (99mTc) pertechnetate is 
taken up by the thyroid gland and also used for thyroid evaluation. This 
isotope is taken up by the mitochondria, but is not organified. It also has the 
advantage of having a shorter half-life and minimizes radiation exposure. It 
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is particularly sensitive for nodal metastases. More recently, 18 F-
fluorodeoxyglucose positron emission tomography (FDG PET) has been 
used to screen for metastases in patients with thyroid cancer, in whom other 
imaging studies are negative. However, this technique is expensive and not 
widely available.  
Ultrasound 
Excellent, noninvasive and portable imaging method and it has the 
added advantage of no radiation exposure. It is helpful in the evaluation of 
thyroid nodules, distinguishing solid from cystic ones, and providing 
information about size and multicentricity.  Assess cervical 
lymphadenopathy, guide fine-needle aspiration (FNA) biopsy. However, it 
cannot be used to image thyroid tissue outside the neck (e.g., to assess the 
extent of a substernal goiter). 
CT/MRI Scan 
Provide excellent imaging of the thyroid gland and adjacent nodes, 
and are particularly useful in evaluating the extent of large, fixed or 
substernal goiters and their relationship to the airway and vascular 
structures. Noncontrast CT scans should be obtained in patients who are 
likely to require subsequent radioactive iodine therapy. 
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FNAC                 
The investigation of choice for discrete thyroid swellings. Excellent 
patient compliance, simple, quick to perform in OP department.  USG 
guided aspiration achieves more accurate sampling and reduces 
unsatisfactory aspirates. There are few false positive with respect to 
malignancy but definite false negative rate with respect to both benign and 
malignant nodules.         
   Its use in the recent years has resulted in a significant 
decrease in the number of thyroid surgeries being performed, while 
increasing the yield of malignant lesions of patients who have undergone  
surgery.      
 
 CLASSIFICATION OF FNAC REPORTS: 
 
THY1      NON DIAGNOSTIC 
THY2      NON NEOPLASTIC 
THY3      FOLLICULAR  
THY4      SUSPICIOUS OF MALIGNANCY 
THY5       MALIGNANT       
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Flow diagram for the evaluation of thyroid nodule based on the results of fine 
needle aspiration biopsy 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 Consider touch preparation.2 Consider total thyroidectomy for large, 
nodular, and/or bilateral lesion, as well as in patients with a history of 
radiation exposure in childhood.      
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MANAGEMENT 
 
Management opted for solitary thyroid nodules are  
 
1. Surgical  
2. Non-Surgical  
 
SURGICAL  
 
Advised after cytological impression  
 
Indications: 
 
1. All proven malignant nodules 
2. All cytologically diagnosed follicular neoplasm 
3. All lesions exhibiting an atypical pattern but non-diagnostic 
cellular pattern on cytology.  
4. All papillary adenomas 
5. Cystic lesion which recurred following aspiration; > 4 cm in size; 
complex in nature.  
6. High suspicion of malignancy on clinical grounds even if cytology 
suggests benign disease and presence of high – risk factors.  
7. Hyper functioning nodule resulting hyperthyroidism.  
8. Obstructive symptoms, actual or potential Patient anxiety 
9. Patient anxiety  
10. Cosmesis.  
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The standard surgical procedure in a benign single nodule should be 
Hemithyroidectomy.  The line of resection should be extended to the 
junction of the isthmus & the contralateral lobe.  
 
 Patients with toxic nodule may be treated by surgery.  Ideal procedure 
is Hemithyroidectomy.  Prior to surgery patient should be brought to 
euthyroid state with propranolol and carbimazole.  Surgical treatment is 
safe, certain and without morbidity.  Patients with toxic nodule over the age 
of 45 years can be treated with radioiodine.  
 
 In patients with differentiated thyroid carcinoma, there are two 
schools of thought,  
 
1. HEMI THYROIDECTOMY  
2. TOTAL OR NEAR TOTAL THYROIDECTOMY  
 
The Treatment objectives in differentiated thyroid cancer are  
 
1. Eradicate primary disease  
2. Reduce the incidence of local / distant recurrence 
3. Facilitate the treatment of metastasis.  
4. Cure the maximum number of patients.  
5. Achieve all of the above with minimal morbidity.  
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In case of micro-papillary carcinoma, and minimally invasive follicular 
carcinoma and the rare encapsulated papillary carcinoma, hemi 
thyroidectomy is the treatment. In all other cases of differentiated thyroid 
cancers total thyroidectomy is the procedure of choice.  
 
There are several arguments for treatment of differentiated thyroid 
cancer by total / near total thyroidectomy.  
 
i) Multifocal disease  
ii) Decreased incidence of local recurrence  
iii) Reduced risk of anaplasia in any residual tissue.  
iv) Facilitation of diagnosing unsuspected metastatic disease by 
radioactive iodine scanning or treatment with I131. 
v) Greater sensitivity of blood thyroglobulin levels to predict 
persistent / recurrent disease.  
 
If total thyroidectomy is contemplated, it is not better than near total 
thyroidectomy in which 1 -  gms of normal thyroid tissue is preserved on the 
contralateral side to protect blood supply to one or more parathyroid glands.  
 
If conservative surgery has been done TSH is suppressed by 
levothyroixine 0.2 – 0.3 mg/day.  But TSH suppression is of doubtful value 
in Low risk patients.  
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In preparing patients for isotope scanning, T4 is stopped 8 weeks 
before and T3 is used for the first 6 weeks and stopped only 2 weeks before 
so that the patient will not develop thyroid insufficiency.  A low iodine diet 
is also recommended during those 2 weeks.  
 
If lymph nodes are affected by secondary deposits in cases of 
papillary carcinoma of MTC and if a nodule of MTC is > 2 cm in size, 
modified neck dissection is performed on the ipsilateral side.  Routine 
central neck node dissection is done for Hurthle cell carcinoma and MTC 
and in cases of involved central nodes bilateral neck dissection should be 
done.  
 
If distant metastases are found, they are treated with large doses of 
131l.  The alternative is TSH suppression with T3.   
  
In patients with medullary carcinoma the treatment of choice is total 
thyroidectomy with central neck node dissection and T3 replacement 
therapy.  Close relatives are screened by estimating serum calcitonin in both 
basal and after pentagastrin or calcium.  If rise in serum calcitonin is 
observed, prophylactic thyroidectomy is done.  Phaeochromocytoma should 
e excluded before surgery, Screening of family members with RET proto-
oncogene point mutation has replaced the provocation tests.  
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In case of anaplastic carcinoma, total thyroidectomy with modified 
neck dissection is treatment of choice but in almost all patients it is not 
respectable.  Isthmusectomy is done to decompress trachea and to obtain 
tissue for histology.  External irradiation should be given in all cases for 
palliation of pain and dyspnoea.  Chemotherapy with Adriamycin or 
Adriamycin, chlorambucil and vincristine combination area advised.  
 
 In case of lymphoma, radical surgery is unnecessary.  Once the 
diagnosis is established by biopsy, Isthmusectomy is done for tracheal 
decompression.  Lymphoma responds well to radio therapy.  
 
THYROIDECTOMY PROCEDURE  
 
For Hemi thyroidectomy 
1. Patient in supine position, neck extended with the help of a 
sandbag placed between the shoulders and rotation of the head is 
avoided by keeping the head on a ring.  
2. A transverse collar incision is made about two finger breadth 
above the clavicle.  
3. Elevation of upper & lower flaps in the plane between platsyma 
and deep cervical fascia.  
4. Vertically incise the deep cervical fascia in the midline.  
5. Vertically split infrahyoid muscles.  
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6. Ligate and divide middle thyroid vein.  
7. Ligate and divide superior thyroid pedicle  
8. Inferior thyroid artery to be ligated in continuity away from the 
gland.  
9. The thyroid isthmus is clamped at the junction with contralateral 
lobe and divided.  
 
For total thyroidectomy:  
The same technique to be followed on contralateral side also. The 
parathyroids are carefully separated and left insitu.  
 
NON SURGICAL MANAGEMENT  
 
Thyroid surgery, even in experienced hands, is associated with definite 
morbidity and should not be undertaken lightly. When the question of 
malignancy with a solitary thyroid nodule has been eliminated by FNAC 
and in the absence of obstructive symptom, it is reasonable to offer the 
patient a conservative line of management. Review the patient after 6 
months, carry out a full cervical examination and repeat the FNAC.  
Provided there is no clinical suspicion of cancer and the cytology again is 
unequivocally benign, the individual is seen on a annual basis for re 
examination and further FNAC. Suppressive dose of exogenous T4 to 
inhibit further growth of solitary thyroid nodule is a controversial question.  
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MATERIALS AND METHODS 
 
 
 
This is a prospective study of randomly selected patients with clinically 
palpable, solitary nodule thyroid diagnosed and treated at Kilpauk Medical 
College Hospital. Total duration of study was two years, from September 
2006 to September 2008. 
Each patient’s symptoms and signs were entered in a proforma (given 
at the end of the dissertation) with clinical examination in relation to the 
thyroid swelling and lymph node involvement and a routine systemic and 
general examination was done. 
All the patients were subjected to basic investigations like complete 
hemogram. Blood sugar, urea, serum cholesterol, urine analysis, chest 
radiogram and neck radiogram. Tissue diagnosis was obtained by fine 
needle aspiration cytology in all these patients. 
Thyroid profile was done in selected patients with features of hyper or 
hypofunctioning of the gland. Radioiodine study was not done since the 
facility was not available at our hospital. Ultrasound of neck and Computed 
Tomogram scan of, chest and skull were done in selected patients. All 
operated specimens were subjected to histopathological examination. 
Preoperative and postoperative complications were analysed. Most cases 
were regularly followed up throughout the study period. All the 
observations were analysed and compared with other studies. 
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OBSERVATION 
 
PREVALENCE OF SOLITARY NODULE THYROID 
TABLE : 1 
NO OF THYROID 
CASES ADMITTED 
SOLITARY THYROID 
NODULE 
PERCENTAGE 
390 80 20.51 
 
Solitary nodule thyroid represents thyroid pathology in about 20.51% 
of case. Out of 80 patients 70 were females and 10 were males. This gives a 
Male: female ratio=1:6.solitary nodule thyroid is 6 times more common in 
women. 
                                                     TABLE : 2 
SEX DISTRIBUTION 
 
 
 
 
 
 
This distribution is in accordance with most of the reported series in 
our country and else where. Considering the total number of admission of 
any thyroid swelling the female incidence is more partly because of 
increased prevalence and partly because of increased cosmetic awareness 
among young females. 
                                                    
SEX MALE FEMALE 
Number of 
patients 
10 70 
Percentage 12.5% 87.5% 
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TABLE:3 
 AGE DISTRIBUTION 
 
 
 
 
 
 
 
In this study the youngest patient was 16 years old and the oldest was 
65 years old.80% of solitary nodules occurred during the age between 21-50 
years. The highest incidence of 33.75 % was recorded during the 4th decade 
of life which is comparable with study done by B. Srinivas Pai, Vijai N. 
Anand, K. Rajgopal Shenoy 
                                                 
                                                   TABLE-4 
 
SIDE OF INVOLVEMENT 
 
 
 
 
 
 
                                                           
                                                                  
 
 
                                                                 
AGE IN 
YEARS 
NO.OF 
PATIENTS PERCENTAGE 
UPTO 
20 5 6.25% 
21-30 25 31.25% 
31-40 27 33.75% 
41-50 11 13.75% 
51-60 10 12.50% 
ABOVE 
60 2 2.50% 
SIDE RIGHT LEFT 
No of 
patients 54 26 
Percentage 68% 32% 
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TABLE-5 
 
                                            CLINICAL PRESENTATION 
 
 
 
 
 
 
 
 
 
All the patients had only single palpable nodule. Toxic symptoms 
were present in 3 patients. Clinical evidence of obstruction to airway or of 
the great veins of neck by a solitary nodule thyroid is rare. Seven patients 
complained of sudden increase in size, while hoarseness of voice was 
present, only in 1 case. In this study, 2 patients had regional 
lymphadenopathy; which on FNAC proved to be secondary deposits from 
papillary carcinoma. 10 patients had difficulty in swallowing and 6 patients, 
pain over the swelling. 2 patients had difficulty in breathing, which was 
mostly uncharacteristic; neither exertional nor positional.  
 
 
 
Clinical 
presentation 
No of 
patients Percentage 
Swelling thyroid 
region 80 100% 
Pain 6 7.5% 
Toxic symptoms 3 3.75% 
Dyspnoea 2 2.5% 
Dysphagia 10 12.5% 
Sudden increase in 
size 7 8.75% 
Regional palpable 
lymphadenopathy 2 2.5% 
Hoarseness of 
voice 1 1.25% 
Hard consistency 4 5% 
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                                                          TABLE-6 
HORMONAL STATUS (CLINICAL) 
HORMONAL 
STATUS 
TOTAL NO. 
OF 
PATIENTS 
PERCENTAGE 
Euthyroid 77 96.25 
Hyperthyroid 3 3.75 
Hypothyroid - - 
 
 DIAGNOSTIC WORKUP: 
              In this study the following investigations were done in all patients 
which included urine analysis, blood sugar, urea, and serum creatinine, plain 
radiograph of neck, IDL scopy, chest radiograph and fine needle aspiration 
cytology. USG and CT scan were done in few cases. Serum T3, T4 and TSH 
estimation were done. CT scan done in a patient with extensive neck 
secondaries. Radionucleotide scanning was not done for any patients due to 
the non-availability of the facility in our hospital. FNAC is the investigation 
of choice for solitary thyroid nodule. In this study FNAC was a very 
dependable and an easy investigation without complications.                            
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TABLE-7 
FNAC REPORT 
SL .NO 
FNAC 
REPORT 
NO OF 
PATIENTS 
1 
FOLLICULAR 
NEOPLASM 
40 
2 
NODULAR  
GOITRE 
31 
3 
PAPILLARY 
CARCINOMA 
6 
4 
HASHIMOTO’S 
THYROIDITIS 
3 
5 
THYROID 
CYST 
- 
 
Amongst the FNAC reports, follicular neoplasm was the most 
common to be reported with the inability to identify vascular/capsular 
invasion. Adenomatous goitre, presenting as a solitary nodule was next 
commonest eventuality. 6 Cases were reported as papillary carcinomas with 
2 of them showing deposits in neck nodes.  
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TABLE-8 
MANAGEMENT DONE 
SL.NO MANAGEMENT NO.OF PATIENTS 
1 Hemithyroidectomy 64 
2 Sub-total thyroidectomy 5 
3 Near total-thyroidectomy 1 
4 
Total thyroidectomy with block 
dissection 
2 
5 
Total thyroidectomy without block 
dissection 
3 
6 Conservative follow up 3 
7 Not willing for surgery 2 
 TOTAL 80 
 
Out of 80 patients, 75 were submitted to surgery with below 
mentioned indications.2 patients were given conservative line of 
management because of IHD with very low ejection fraction. One another 
patient with Hashimoto’s thyroiditis also was put on conservative treatment. 
2 patients were not willing for surgery. These patients were advised regular 
follow up, on a half yearly basis for re-examinations and repeat FNAC. 
Repeat FNAC was done in 2 of these patients and were reported benign.   
Provided there is no clinical suspicion of cancer and the cytology is again 
unequivocally benign, the individuals are seen on an annual basis for re-
examination and further FNAC (RUSSEL). 
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TABLE-9 
INDICATIONS FOR SURGERY 
SL.NO INDICATIONS FOR SURGERY 
NO.OF 
PATIENTS 
1 Cytology proven malignancy 6 
2 Cytology diagnosis as follicular neoplasm 40 
3 Clinical suspicion of malignancy 1 
4 Toxic nodule 3 
5 Cosmetic 25 
 Total 75 
 
This study includes three cases of solitary thyroid nodule with 
hyperthyroidism with benign cytology report. For these patients 
Hemithyroidectomy was done after preparation with anti-thyroid drugs, on 
the assumption that the solitary nodule is the overactive tissue, since 
radioisotope scan was not available to study the functional status of the 
nodule and these patients had no recurrence thyrotoxicosis. 
 
                 Total thyroidectomy was done for 5 patients of papillary 
carcinoma with functional neck node dissection in 2 patients. Near-total 
thyroidectomy was done for a patient with papillary carcinoma leaving 
behind a strip of tissue on the side other than the nodule. 
 
                Sub-total thyroidectomy was done for a 5 patients who had 
nodules on contralateral   lobe peroperatively. Hemi-thyroidectomy, the 
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standard surgical procedure for solitary nodule thyroid was done in 64 
patients i.e., about 84% of patients who underwent surgery. All resected 
specimens were submitted to histopathological examination. 
 
TABLE-10 
HISTOPATHOLOGICAL REPORT 
HPE REPORT NO. OF PATIENTS PERCENTAGE 
CARCINOMA: 
Papillary carcinoma and 
follicular variant of 
papillary carcinoma 
Follicular carcinoma 
10 
 
8 
 
 
2 
13.33% 
Follicular adenoma 36 48% 
Nodular goitre 27 36% 
Hashimoto’s thyroiditis 2 2.67% 
Total 75  
 
Histology proven malignancy in this series of study of solitary thyroid 
nodule is 13.33% of which 80% (8 cases) were of papillary carcinoma and 
its variant and the rest 20% (2 cases) were follicular carcinoma types. Of 
these, six cases were diagnosed preoperatively and were offered the 
confirmative treatment the rest four cases were diagnosed only on HPE 
reporting & then underwent completion total thyroidectomy without neck 
dissection. All these patients are under regular follow up with suppressive 
doses of thyroxine. 
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DISCUSSION 
The estimated life time risk of developing a nodule in the thyroid was 
projected to be between 5-10%, according to a prospective study conducted 
in Framingham, Massachusetts, in 1950s & 1960s. According to the study 
conducted by Prof .R.L. Gupta University College of medical science, Delhi 
right lobe involvement is more 51.4% compared to left lobe involvement of 
38.8% which is comparable with our study with right lobe involving 68% 
and left lobe 32%. 
 
In a study conducted in   MKG medical college Berhrampur Orissa 
(1990-1998) under Prof. M.C.Dandapat, Dr. L.M.Mukarjee concluded that 
the maximum number of cases recorded during the 3rd and 4th decade of life 
with a female & male ratio of  5:1 which is comparable with our study 
which has a ratio of  6:1. Nagori et al reported the maximum incidence of 
SNG of 29% during the 4th decade.   The commonest site of SNG was right 
lobe. The percentage of malignancy was 11.1%. In a study   Dr.H.Koticha & 
R.M.S Kamdar Mumbai concluded that, estimation of thyroid hormone 
levels has made no significant impact in deciding about surgery. FNAC is 
safe, simple diagnostic but surgery is mandatory. 
 
After an analysis of 100 cases of thyroid nodules, Prof. R.C. 
Suryaprakash concluded that among the thyroid disorder adenoma thyroid 
was the commonest benign lesions, papillary carcinoma was the commonest 
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malignancy. Hashimoto’s thyroiditis has got the highest incidence among 
the middle aged women.  
                      
Comparison of pre-operative FNAC with post-operative 
Histopathological examination: 
Out of 75 cases operated 5 had different HPE reports as compared to FNAC 
reports. If both FNAC & HPE are benign or malignant they are considered 
as true positive.4 cytologically benign lesions were reported as malignant on 
HPE. So FNAC was false negative in these cases.  
 
TABLE-11 
ACCURACY RATE OF FNAC 
RESULT 
True 
positive 
cases 
False 
negative 
False 
positive 
TOTAL 
NO. OF 
CASES 
71 4 0 75 
PERCENTAGE 94.6% 5.3% 0 100 
 
In comparison an overall accuracy rate greater than 94% was achieved in the 
cytological diagnosis of SNG. The main goal of FNAC is to accurately predict 
which nodule is cancerous. Numerous studies cited the following data. 
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Sensitivity is 65% to 100%, specificity is 70% to 100%. Overall accuracy rate 
is estimated to be 92-95%.in most series false positive rate is approximately 
0.8% - 9% & the false negative rate is 0-16%. Most expertise agrees that the 
actual false negative rate is less than 5%.   
         
 
 CANCER RISK IN FOLLICULAR NEOPLASM 
 
The cytological appearances of follicular adenoma and carcinoma are 
very similar. So a cytological diagnosis of follicular neoplasm is only 
possible, and confirmation of diagnosis of follicular carcinoma depends 
upon the visualization of capillary & capsular invasion in HPE. Although 
the cancer risk is only 20%, CFJ RUSSEL, in common with others advises 
surgical resection of all solitary thyroid nodules reported as follicular 
neoplasm cytologically. In this study 40 cases were diagnosed as follicular 
neoplasm cytologically and of these 4 were histologically malignant -10% 
cancer risk. Fenn & Krishnan 1976 & others found that there was no great 
sex predominance in the incidence of malignancy. A solitary nodule in very 
young patients almost malignant & in middle age it is rarely to be malignant 
and the incidence of malignancy increasing with the age told by Selwyn & 
Taylor in 1969.  
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The incidence of thyroid cancer in patients with a solitary thyroid 
nodule as follows 
Study by Kendall & Condon  1969 }
Pnarras et al 1972} 
11-20% 
Study by Colin F J Russell at Royal 
Victoria hospital, BELFAST., UK 
13% 
Study by Fenn & Krishnan at CMC 
Vellore, Tamilnadu 
12.6% 
Study by Nagori et al 1992 11% 
Study by Dr.L.M.Mukerjee & 
Prof.M.C. Dandapet, MKG medical 
college, Berhampur Orissa 
11.1% 
Study conducted in Kilpauk Medical 
College, Chennai  2006-2008 
13.33% 
 
This compares well with the other studies on solitary nodule goitre. 
The maximum incidence of malignancy of 29% of cases was present during 
the 4th decade. The incidence of malignancy in females & males was almost 
equal in all decades from the 2nd but the incidence in male was common in 
5th and 6th decades in study by Lt Nagori in 1992.    
           
           
          
83 
 
TABLE-12 
AGE & SEX DISTRIBUTION OF BENIGN AND MALIGNANT                    
                                                         NODULE 
 
In our study 40% of solitary nodule in males proved to be malignant 
whereas in females only about 9% of the solitary nodules harboured 
malignancy. According to Matheson 1986, the malignant potential of a 
nodule in a man is approximately three times that for a woman of 
comparable age and in our study, the risk has been almost four times. In 
males 75% of cancer occurred in more than 40 years age group. Malignancy 
is more likely in a nodule in a child or a teenager or when goitre develops in 
MALES FEMALES 
AGE in 
years BENIGN 
MALIGNAN
T 
TOTAL BENIGN 
MALIGNAN
T 
TOTAL 
Upto 
20 
1 1 2 2 1 3 
21-30 1 0 1 21 0 21 
31-40 1 0 1 22 3 25 
41-50 2 2 4 7 0 7 
51-60 1 1 2 7 0 7 
60 & 
above 
0 0 0 0 2 2 
TOTA
L 
6 4 10 59 6 65 
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a patient aged 60 years & above (Hamming et al 1990, Caruso and 
Mazzaferri 1991). 
 
     50% of thyroid cancers occurred in individuals under 40 years of 
age and of them 80% of them is papillary carcinoma. Fravenhofer et al 1970 
in his study of 125 cases of thyroid cancer found that 80% of thyroid 
cancers in individual less than 40 years of age were papillary carcinoma. 
 
TABLE- 13 
HISTOLOGICALLY PROVEN MALIGNANCY 
TYPE No OF PATIENTS PERCENTAGE 
PAPILLARY CA 8 80 
FOLLICULAR CA 2 20 
MEDULLARY CA 0 0 
 
No medullary carcinoma, anaplastic carcinoma and lymphoma were 
reported in our series. The relative incidence of primary malignant tumors in 
our series is almost in accordance with most of the reported series.  
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SURGICAL PROCEDURES 
CARCINOMA 
 
                      We have done total thyroidectomy with or without neck 
dissection in five patients. All the five were papillary carcinoma. Near total 
thyroidectomy was done for a case, also of papillary carcinoma. Total 
thyroidectomy is considered not only as a measure to reduce the recurrence 
rate of differentiated carcinoma but also as a means of preventing 
development of a highly undifferentiated lesion. The percentage of 
radioiodine pick up can be increased several fold after total thyroidectomy 
and it is also increases the sensitivity of thyroglobulin as a postoperative 
marker of residual/recurrent disease. 
 
DISADVANTAGE 
 The risk of permanent hypoparathyroidism or recurrent laryngeal 
nerve damage is high. We have done near total thyroidectomy for one 
patient, a case of cytologically proved papillary carcinoma, which was a 
small lesion (1.5cm) preserving one parathyroid. Indications for near total 
thyroidectomy, includes smaller lesions and better prognostic variants of 
papillary carcinoma. 
   Out of four false negative patients (cytologically benign) all were 
treated with Hemithyroidectomy. All these patients were taken up for 
completion thyroidectomy because they had an uneventful postoperative 
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period and follow up. In our study 3 patients with clinical toxicity were 
reported as follicular neoplasm and as follicular adenoma in HPE. Out of 75 
cases operated 36 cases reported as adenoma in HPE report. 
Hemithyroidectomy done for all patients. 36% of operated cases were 
diagnosed as nodular goitre, Hemithyroidectomy done for most of them. 5 
patients had nodules in the contra lateral lobe also, who were revealed 
peroperatively, and hence subtotal thyroidectomy was done.   
 
OUT COME OF THERAPY 
Complications: 
  Out of the 75 patients operated, two developed features of 
hypocalcaemia in the immediate postoperative period and were revived with 
intravenous, calcium gluconate and with no need for oral calcium 
supplementation.  
Two patients had sluggish movement of left vocal cord after total 
thyroidectomy and improved later. Three patients had postoperative wound 
infection. We had no mortality during this study. 
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 COMPARISON OF STUDY 
  
Study by Colin FJ Russel FRCS at 
Royal Victoria Hospital Belfast, U.K 
61 patients operated for solitary thyroid 
nodule 
Study at Kilpauk Medical College 
Hospital  Kilpauk Chennai 
75 patients operated for solitary 
thyroid nodule 
FNAC 
Pathological 
Diagnosis 
Number 
of patients
Percentage Number of 
patients 
 Percentage 
Nodular 
goitre  
30 49 27 36 
Follicular 
adenoma 
19 31 36 48 
Malignancy  8 13 10 13.33 
Hashimoto’s 
thyroiditis 
3 5 2 2.67 
Dequervains  1 2 - - 
Simple cyst - - - - 
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CONCLUSIONS 
 
¾ From our study, the common causes of SNT are adenoma, a dominant 
nodule of MNG, Hashimoto’s thyroiditis in the benign variety while 
papillary & follicular carcinomas were among the malignant causes. 
¾ Among the SNT adenoma (48%) is the most common lesion & 
papillary carcinoma (80%) is the most common malignancy. 
¾ The incidence of SNT is very high among females (87.5%) 
comparing with males (12.5%) but the malignancy rate is high among 
males (40%) comparing with females (9.2%). 
¾ SNT more common in the right lobe (68%) than the left lobe (32%). 
¾ The incidence of toxic symptoms in SNT is very less (3.75%). 
¾ The incidence of malignant lesion is 13.33%. 
¾ The incidence of SNT highest in the age group of 21-40 years with a 
65% of patients falling in this age category. 
¾ FNAC is the gold standard test for evaluating SNT with accuracy rate 
of 94.6%. 
¾ USG & Radioiodine study are supplementary to FNAC. 
¾ A surgical procedure in any form remains diagnostic as well as 
therapeutic even though the trend now is non-surgical management 
with close follow up for the most of the benign lesions. 
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¾ HPE remains to be the final diagnostic proof. According to that 
results the management strategies varies. 
¾ Follow up is essential in SNT because unlike other malignancies 
thyroid carcinoma are easily amenable to cure, have got better 
prognosis & prolonged survival rate. 
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SIDE OF INVOLVEMENT IN SNT
68%
32%
RIGHT LEFT
 
 
 
 
 
SEX DISTRIBUTION OF SNT
87.5
12.5
MALE FEMALE
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INCIDENCE OF SOLITARY NODULE THYROID ACCORDING 
TO AGE
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FNAC REPORTS
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HPE REPORTS 
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A STUDY ON CLINICOPATHOLOGICAL 
EVALUATION 
OF SOLITARY NODULE OF THYROID 
 
 Age   Sex   Unit    IP No.  
 
   DOS :    DOD : 
 
PRESENTING COMPLAINTS  
 
Swelling    - Onset 
     Duration  
     Rate of Growth 
     Associated Pain  
 
Pressure Effect   - Dyspnoea  
     Dysphagia 
     Hoarseness of Voice  
Symptoms of Thyrotoxicosis  
Symptoms of Hypothyroidism 
History of irradiation of face and neck  
Family history of Thyroid Malignancy  
Any other systemic illness.  
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GENERAL EXAMINIATION  
 
Pulse rate    : Eye Signs  
Blood Pressure   : Skin Changes  
     Tremors  
 
LOCAL EXAMINIATION  
Thyroid Swelling: 
 
 Site    : Border     : 
 Size    : Consistency    : 
 Shape    : Movement with Deglutition  : 
 Surface    : Mobility     : 
 Extent    : Tracheal Position    : 
 Regional Lymph nodes : 
 
SYSTEMIC EXAMINATION  
 
 CNS    : 
 RS    : 
 Abdomen    : 
 SKELETAL SYSTEM  : 
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PROVISIONAL DIAGNOSIS  
INVESTIGATIONS   
 
Haemoglobin    :   Urine analysis : 
Blood Sugar    :   Blood Urea   : 
Serum Cholesterol   :   Thyroid Profile  : 
Chest X ray    :   Xray neck   : 
USG     :   CT Scan   : 
IDL Scopy     :   FNAC  : 
Biopsy report    : 
 
TYPE OF SURGERY   : 
POST OPERATIVE COMPLICATIONS:  
 
  
 
                   
 
 
 
 
 
 
 
 
 
 
102 
 
 
 
 
 
 
 
 
ABBREVATIONS 
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ABBREVATIONS 
 
FA Æ FOLLICULAR ADENOMA 
NG Æ NODULAR GOITRE 
HASHI Æ HASHIMOTO’S THYROIDITIS 
FOLL CA Æ FOLLICULAR CARCINOMA 
PAP CA Æ PAPILLARY CARCINOMA 
HT Æ HEMITHYROIDECTOMY 
CT Æ COMPLETION THYROIDECTOMY 
NTT Æ NEAR TOTAL THYROIDECTOMY 
TT Æ TOTAL THYROIDECTOMY 
LND Æ LYMPH NODE DISSECTION 
p Æ present 
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